Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer
Yiding Wang, Xiaoling Pang, Yuexin Liu, et al.
Carcinogenesis (2023) Vol. 44, Iss. 8-9, pp. 708-715
Closed Access | Times Cited: 12

Showing 12 citing articles:

Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Chufei Xie, Liujia Chan, Yuheng Pang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 4
LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression
Yaobang Liu, Haipeng Li, Dahai Chai, et al.
Translational Oncology (2025) Vol. 53, pp. 102210-102210
Closed Access | Times Cited: 1
Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
Yaru Wang, Yue Sun, Feiran Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115866-115866
Open Access | Times Cited: 14
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)
Leyu Ai, Na Yi, Chunhan Qiu, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 4
Current knowledge of ferroptosis in the pathogenesis and prognosis of oral squamous cell carcinoma
Liyuan Zhou, Youjun Wu, Yukang Ying, et al.
Cellular Signalling (2024) Vol. 119, pp. 111176-111176
Closed Access | Times Cited: 4
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Pinoresinol Diglucoside Attenuates Nuclear Receptor Coactivator 4‐Mediated Ferritinophagy Associated with Cisplatin‐Induced Hearing Loss
Yin Chen, Cheng Cheng, Ao Li, et al.
Advanced Science (2025)
Open Access
Paris saponin VII promotes ferroptosis to inhibit breast cancer via Nrf2/GPX4 axis
Yan Chen, Xuan Fei
Biochemical and Biophysical Research Communications (2024) Vol. 697, pp. 149524-149524
Closed Access | Times Cited: 3
TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1
Chunxiang Yu, Juan Wang, Yan Li
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study
Junlin Liu, Rong Tang, Jie Zheng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Distinct microbiome dysbiosis and epigenetic anomaly in esophageal adenocarcinoma and its underlying Barrett’s esophagus
Takuya Shijimaya, Tomomitsu Tahara, Jumpei Yamazaki, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access
Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer
Cuixin Peng, Yanning Chen, Min‐Li Jiang
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top